alexa Feasibility Of Using HUmbilical Cord Serum As An Alternative To Fetal Calf Serum In Culture Systems | 7173
ISSN: 2161-0665

Pediatrics & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Feasibility of using hUmbilical Cord Serum as an alternative to Fetal Calf Serum in Culture Systems

2nd International Conference on Pediatrics & Gynecology

Vijayalakshmi Venkatesan, S. S. Challa, SashiKiran G and R. R. Bhonde

ScientificTracks Abstracts: J Pediatr Therapeut

DOI: 10.4172/2161-0665-S1.010

Fetal calf serum (FCS) is conventionally used for animal cell cultures due to its inherent growth promoting activities. However animal welfare issues and stringent requirements for human transplantation studies demand a suitable alternative for FCS. With this view, we have investigated the effects of hUmbilical Cord Serum( hUCBS) and FCS on the viability , proliferation and its differentiation potential to generate islet like cellular aggregates (ICAs) using the human derived Panc-1 cell lines. A comparative analysis of hUCBS and FCS for each parameter demonstrated that hUCBS supplemented media was better for proliferation and differentiation of the Panc-1 cells (stem cells) . The ICAs obtained from hUCBS primed cultures showed a higher yield, increased islet size, and showed an increase for insulin staining compared to FCS. A comparative analysis of hBone Marrow cells (hBMCs) maintained in each of these different serum supplements demonstrated that hUCBS supplemented media better supported proliferation of hBMCs and enhanced adipogenic differentiation protocol than FCS.We suggest that hUCBS can be explored as an alternate serum supplement for FCS, making it more feasible in cell systems of human derived origin as this is xenogenic free and can also find its application for the human transplantation programmes.

Vijayalakshmi Venkatesan is currently working as a Scientists E, HOD of Biochemistry/Stem Cell research/Instrumentation at National Institute of Nutrition. She has done 12 projects till now and has 60 publications to her credit. She is a member of Indian Society of Stem cells and Indian Women?s Scientists Association. She has got Young Investigator?s Award for best paper & presentation in the Joint Conference between Indian Association for Study of Liver (INASL) and European Association for the Study of the Liver, Best paper & presentation Award by Indian Association For Gastroenterology & Indian Association For Liver Diseases. Poona and ICMR International Fellowship for Senior Biomedical scientists to visit Karolinska Institutet, Sweden, 2010.

Leave Your Message 24x7